These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 30269956)

  • 21. The utility of ultrafast MRI and conventional DCE-MRI for predicting histologic aggressiveness in patients with breast cancer.
    Kim SG; Park AY; Jung HK; Ko KH; Kim Y
    Acta Radiol; 2024 Oct; 65(10):1186-1195. PubMed ID: 39295306
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ultrafast dynamic contrast-enhanced breast MRI may generate prognostic imaging markers of breast cancer.
    Onishi N; Sadinski M; Hughes MC; Ko ES; Gibbs P; Gallagher KM; Fung MM; Hunt TJ; Martinez DF; Shukla-Dave A; Morris EA; Sutton EJ
    Breast Cancer Res; 2020 May; 22(1):58. PubMed ID: 32466799
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dynamic contrast-enhanced MRI of the breast: quantitative method for kinetic curve type assessment.
    El Khouli RH; Macura KJ; Jacobs MA; Khalil TH; Kamel IR; Dwyer A; Bluemke DA
    AJR Am J Roentgenol; 2009 Oct; 193(4):W295-300. PubMed ID: 19770298
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Can imaging kinetic parameters of dynamic contrast-enhanced magnetic resonance imaging be valuable in predicting clinicopathological prognostic factors of invasive breast cancer?
    Wang C; Wei W; Santiago L; Whitman G; Dogan B
    Acta Radiol; 2018 Jul; 59(7):813-821. PubMed ID: 29105486
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ultrafast Dynamic Contrast-enhanced MRI of the Breast: How Is It Used?
    Kataoka M; Honda M; Ohashi A; Yamaguchi K; Mori N; Goto M; Fujioka T; Mori M; Kato Y; Satake H; Iima M; Kubota K
    Magn Reson Med Sci; 2022 Mar; 21(1):83-94. PubMed ID: 35228489
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differences Between Ipsilateral and Contralateral Early Parenchymal Enhancement Kinetics Predict Response of Breast Cancer to Neoadjuvant Therapy.
    Ren Z; Pineda FD; Howard FM; Hill E; Szasz T; Safi R; Medved M; Nanda R; Yankeelov TE; Abe H; Karczmar GS
    Acad Radiol; 2022 Oct; 29(10):1469-1479. PubMed ID: 35351365
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combining dynamic contrast enhanced magnetic resonance imaging and microvessel density to assess the angiogenesis after PEI in a rabbit VX2 liver tumor model.
    Chen J; Qian T; Zhang H; Wei C; Meng F; Yin H
    Magn Reson Imaging; 2016 Feb; 34(2):177-82. PubMed ID: 26518059
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diffusion-Weighted Imaging With Apparent Diffusion Coefficient Mapping for Breast Cancer Detection as a Stand-Alone Parameter: Comparison With Dynamic Contrast-Enhanced and Multiparametric Magnetic Resonance Imaging.
    Pinker K; Moy L; Sutton EJ; Mann RM; Weber M; Thakur SB; Jochelson MS; Bago-Horvath Z; Morris EA; Baltzer PA; Helbich TH
    Invest Radiol; 2018 Oct; 53(10):587-595. PubMed ID: 29620604
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Compressed Sensing for Breast MRI: Resolving the Trade-Off Between Spatial and Temporal Resolution.
    Vreemann S; Rodriguez-Ruiz A; Nickel D; Heacock L; Appelman L; van Zelst J; Karssemeijer N; Weiland E; Maas M; Moy L; Kiefer B; Mann RM
    Invest Radiol; 2017 Oct; 52(10):574-582. PubMed ID: 28463932
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Automatic identification and classification of characteristic kinetic curves of breast lesions on DCE-MRI.
    Chen W; Giger ML; Bick U; Newstead GM
    Med Phys; 2006 Aug; 33(8):2878-87. PubMed ID: 16964864
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tumor segmentation analysis at different post-contrast time points: A possible source of variability of quantitative DCE-MRI parameters in locally advanced breast cancer.
    Romeo V; Cavaliere C; Imbriaco M; Verde F; Petretta M; Franzese M; Stanzione A; Cuocolo R; Aiello M; Basso L; Amitrano M; Lauria R; Accurso A; Brunetti A; Salvatore M
    Eur J Radiol; 2020 May; 126():108907. PubMed ID: 32145597
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of dynamic contrast-enhanced MRI parameters of breast lesions at 1.5 and 3.0 T: a pilot study.
    Pineda FD; Medved M; Fan X; Ivancevic MK; Abe H; Shimauchi A; Newstead GM; Karczmar GS
    Br J Radiol; 2015 May; 88(1049):20150021. PubMed ID: 25785918
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bilateral asymmetry of quantitative parenchymal kinetics at ultrafast DCE-MRI predict response to neoadjuvant chemotherapy in patients with HER2+ breast cancer.
    Ren Z; Pineda FD; Howard FM; Fan X; Nanda R; Abe H; Kulkarni K; Karczmar GS
    Magn Reson Imaging; 2023 Dec; 104():9-15. PubMed ID: 37611646
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnostic performance of maximum slope: A kinetic parameter obtained from ultrafast dynamic contrast-enhanced magnetic resonance imaging of the breast using k-space weighted image contrast (KWIC).
    Ohashi A; Kataoka M; Kanao S; Iima M; Murata K; Weiland E; Onishi N; Kawai M; Toi M; Togashi K
    Eur J Radiol; 2019 Sep; 118():285-292. PubMed ID: 31324411
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Potential of Noncontrast Magnetic Resonance Imaging With Diffusion-Weighted Imaging in Characterization of Breast Lesions: Intraindividual Comparison With Dynamic Contrast-Enhanced Magnetic Resonance Imaging.
    Baltzer PAT; Bickel H; Spick C; Wengert G; Woitek R; Kapetas P; Clauser P; Helbich TH; Pinker K
    Invest Radiol; 2018 Apr; 53(4):229-235. PubMed ID: 29190227
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel High Spatiotemporal Resolution Versus Standard-of-Care Dynamic Contrast-Enhanced Breast MRI: Comparison of Image Quality.
    Morrison CK; Henze Bancroft LC; DeMartini WB; Holmes JH; Wang K; Bosca RJ; Korosec FR; Strigel RM
    Invest Radiol; 2017 Apr; 52(4):198-205. PubMed ID: 27898602
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Early prediction of pathologic complete response of breast cancer after neoadjuvant chemotherapy using longitudinal ultrafast dynamic contrast-enhanced MRI.
    Cao Y; Wang X; Li L; Shi J; Zeng X; Huang Y; Chen H; Jiang F; Yin T; Nickel D; Zhang J
    Diagn Interv Imaging; 2023 Dec; 104(12):605-614. PubMed ID: 37543490
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Time-to-enhancement at ultrafast breast DCE-MRI: potential imaging biomarker of tumour aggressiveness.
    Shin SU; Cho N; Kim SY; Lee SH; Chang JM; Moon WK
    Eur Radiol; 2020 Jul; 30(7):4058-4068. PubMed ID: 32144456
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A preliminary study of the combination of ultrafast and abbreviated dynamic contrast: Enhanced breast magnetic resonance imaging.
    Jeong SM; Ha SM; Ahn HS; Woo S; Sung JK; Shin HC
    Medicine (Baltimore); 2020 Dec; 99(50):e23415. PubMed ID: 33327267
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Performance of Ultrafast DCE-MRI for Diagnosis of Prostate Cancer.
    Chatterjee A; He D; Fan X; Wang S; Szasz T; Yousuf A; Pineda F; Antic T; Mathew M; Karczmar GS; Oto A
    Acad Radiol; 2018 Mar; 25(3):349-358. PubMed ID: 29167070
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.